Vyvanse (lisdexamfetamine)

Vyvanse (lisdexamfetamine) is a prescription medication used to treat conditions like ADHD and binge eating disorder, making it an important tool in managing these disorders.

Studies have found that Vyvanse can effectively reduce symptoms of ADHD by improving attention and reducing hyperactivity. It has also been shown to help with binge eating behaviors. However, the use of Vyvanse is associated with potential side effects such as insomnia and weight gain. These findings are supported by a systematic review and meta-analysis.

The strongest connections here highlight that Vyvanse can cause insomnia and may lead to weight gain in some users. These effects should be monitored closely when using the medication.

While there is substantial evidence supporting its efficacy, more research could provide deeper insights into long-term use and broader safety profiles.

Sources

• Lisdexamfetamine. (PMID:17407369)
• LISDEXAMFETAMINE (VYVANSE) USE ASSOCIATED WITH BRANCH RETINAL ARTERY OCCLUSION. (PMID:36007252)
• A systematic review of the safety of lisdexamfetamine dimesylate. (PMID:24788672)
• Lisdexamfetamine's Efficacy in Treating Attention Deficit Hyperactivity Disorder (ADHD): A Meta-Analysis and Review. (PMID:39350825)
• Psychopharmacologic Management of Eating Disorders. (PMID:35576089)
• Lisdexamfetamine. (PMID:30000800)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._